| 货号 |
中文名称 |
英文名词 |
靶点 |
|
VAPD00115 |
Research Grade Alacizumab(阿拉赛珠单抗 ) Biosimilar
|
|
KDR, FLK1, VEGFR2，Protein-tyrosine kinase receptor flk-1, Kinase insert domain receptor, CD309 |
|
VAPD00114 |
Research Grade Dacetuzumab ( 达西组单抗 ) Biosimilar
|
|
CD40, TNFRSF5, B-cell surface antigen CD40 |
|
VAPD00110 |
Research Grade Anrukinzumab ( 安芦组单抗 ) Biosimilar
|
|
IL13, NC30, Interleukin-13, IL-13 |
|
VAPD00109 |
Research Grade Clivatuzumab Tetraxetan( 泰坦-克利妥珠单抗 ) Biosimilar
|
|
MUC1, MUC-1, PEM, PUM, PEMT, H23AG, EMA, CD227 |
|
VAPD00113 |
Research Grade Tenatumomab ( 替妥莫单抗 ) Biosimilar
|
|
TNC, HXB, Tenascin, Cytotactin, GMEM |
|
VAPD00112 |
Research Grade Racotumomab ( 雷妥莫单抗 ) Biosimilar
|
|
idiotope of anti-(N-glycolylneuraminic acid (NeuGc, NGNA) -gangliosides GM3) Mus musculus IgM-kappa |
|
VAPD00111 |
Research Grade Conatumumab ( 可那木单抗 ) Biosimilar
|
|
TNFRSF10B, DR5, KILLER, TRAILR2, TRICK2, ZTNFR9 |
|
VAPD00106 |
Research Grade Panitumumab ( 帕木单抗 ) Biosimilar
|
|
EGFR |
|
VAPD00105 |
Research Grade Golimumab ( 戈利木单抗 ) Biosimilar
|
|
TNF, TNFA, TNFSF2,TNF-alpha, TNF-α, TNFα |
|
VAPD00104 |
Research Grade Dorlimomab( 阿托度单抗 ) Biosimilar
|
|
(ricin A chain) immunotoxin |
